FADS4 typically presents with a range of symptoms that may include joint contractures (stiffness), underdeveloped muscles, and facial abnormalities. These symptoms are often detectable via ultrasound during pregnancy. The lack of movement can also lead to pulmonary hypoplasia, a condition where the lungs are underdeveloped, potentially causing severe breathing difficulties at birth.

Diagnosing FADS4 involves a combination of prenatal imaging, genetic testing, and clinical evaluation. Ultrasound can reveal reduced fetal movement and associated physical abnormalities. Genetic testing may identify mutations linked to the disorder. A thorough clinical assessment post-birth can confirm the diagnosis by evaluating the extent of physical and developmental issues.

There is no cure for FADS4, and treatment focuses on managing symptoms and improving quality of life. This may involve physical therapy to enhance mobility and prevent further joint contractures. In some cases, surgical interventions might be necessary to correct severe deformities. Respiratory support may be required for infants with lung underdevelopment.

The prognosis for individuals with FADS4 varies depending on the severity of symptoms and associated complications. Early intervention and supportive care can improve outcomes, but severe cases may result in significant physical and developmental challenges. Lifespan may be reduced, particularly if respiratory issues are severe.

FADS4 is caused by genetic mutations that affect the normal development of the fetus. These mutations can disrupt the signals necessary for muscle movement, leading to the characteristic lack of fetal movement. The specific genes involved can vary, and the condition may be inherited in an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene.

FADS4 is an extremely rare condition, with only a limited number of cases reported worldwide. Its rarity makes it challenging to determine precise incidence rates. The disorder affects both males and females equally and can occur in any ethnic group.

The pathophysiology of FADS4 involves a disruption in the normal signaling pathways that control muscle movement during fetal development. This lack of movement leads to a cascade of developmental issues, including joint contractures and muscle underdevelopment. The reduced movement also affects lung development, contributing to respiratory complications.

Currently, there are no known methods to prevent FADS4, as it is a genetic condition. Genetic counseling may be beneficial for families with a history of the disorder to understand the risks and consider options for future pregnancies.

Fetal Akinesia Deformation Sequence 4 is a rare genetic disorder characterized by a lack of fetal movement, leading to a range of physical and developmental challenges. Diagnosis involves prenatal imaging and genetic testing, while treatment focuses on managing symptoms. The condition's rarity and genetic basis make prevention difficult, but early intervention can improve outcomes.

FADS4 is a rare condition that affects a baby's movement before birth, leading to joint stiffness and other physical issues. It is caused by genetic changes and can be detected through ultrasound and genetic tests. While there is no cure, treatments like physical therapy can help manage symptoms. Families with a history of FADS4 may benefit from genetic counseling to understand their risks.